Systemic carboplatin for retinoblastoma: Change in tumour size over time Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carboplatin
  • Retinal Neoplasms
  • Retinoblastoma

abstract

  • Carboplatin caused measurable shrinkage of retinoblastoma tumours. Response was greatest following the initial treatment and decreased with subsequent treatments.

publication date

  • December 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC1772963

Digital Object Identifier (DOI)

  • 10.1136/bjo.2005.072033

PubMed ID

  • 16299142

Additional Document Info

start page

  • 1616

end page

  • 9

volume

  • 89

number

  • 12